CHUNGHWA CHEMICAL SYNTHESIS BIOT LTCHUNGHWA CHEMICAL SYNTHESIS BIOT LTCHUNGHWA CHEMICAL SYNTHESIS BIOT LT

CHUNGHWA CHEMICAL SYNTHESIS BIOT LT

No trades
See on Supercharts

1762 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the manufacture, research and development of active pharmaceutical ingredients (API). Its products include pain management for skeletal muscle pain & migraine, immunosuppressant for reducing immune activity after organ transplant, antifungal such as fluconazole, caspofungin & micafungin, oncology that act against cancers, lowering cholesterol & chronic heart disease and other APIs for lowering cholesterol and anti diabetic drugs. The company was founded on May 19, 1964 and is headquartered in New Taipei, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
1762 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company